Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on sleep in brain health

LIVE: Thursday 2nd May 2024, 18:00-19:30 (CEST)

Quality sleep is essential for health. But what happens to our brains when sleep patterns are disturbed? Join our experts to explore the interplay between sleep disruption and neurological diseases, and the questions that you need to be asking your patients to help you prevent the harmful effects of sleep deprivation.
ADVANCED SEARCH
Log in
Top
Clinical & Experimental Metastasis
Metadata
Title
Overexpression of tissue inhibitor of matrix metalloproteinases-1 (TIMP-1) in metastatic MDCK cells transformed by v-src
Authors
Hanae Noritake
Hisashi Miyamori
Chisa Goto
Motoharu Seiki
Hiroshi Sato
Publication date
01-03-1999
Publisher
Kluwer Academic Publishers
Published in
Clinical & Experimental Metastasis / Issue 2/1999
Print ISSN: 0262-0898
Electronic ISSN: 1573-7276
DOI
https://doi.org/10.1023/A:1006596620406

Other articles of this Issue 2/1999

Clinical & Experimental Metastasis 2/1999 Go to the issue

OriginalPaper

Matrix-degrading proteinases are shed in membrane vesicles by ovarian cancer cells in vivo and in vitro

OriginalPaper

The matrix metalloproteinase inhibitor batimastat inhibits angiogenesis in liver metastases of B16F1 melanoma cells

OriginalPaper

A novel orthotopic model of breast cancer metastasis to bone

OriginalPaper

Characterization of a highly metastatic, orthotopic lung cancer model in the nude rat

OriginalPaper

Involvement of small GTPases Rho and Rac in the invasion of rat ascites hepatoma cells

OriginalPaper

Malignant and other properties of human colon carcinoma cells after suppression of sulfomucin production in vitro
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits